A5046645298- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
- Psoriasis: Treatment and Pathogenesis
- Autoimmune and Inflammatory Disorders Research
- Bone and Joint Diseases
- Systemic Lupus Erythematosus Research
- Osteomyelitis and Bone Disorders Research
- Infectious Diseases and Tuberculosis
- Inflammatory Myopathies and Dermatomyositis
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Spine and Intervertebral Disc Pathology
- Inflammatory Bowel Disease
- Autoimmune and Inflammatory Disorders
- Gout, Hyperuricemia, Uric Acid
- Vasculitis and related conditions
- Inflammasome and immune disorders
- Orthopedic Infections and Treatments
- Inflammatory mediators and NSAID effects
- Cytokine Signaling Pathways and Interactions
- Peripheral Neuropathies and Disorders
- Systemic Sclerosis and Related Diseases
- Bone health and treatments
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Microscopic Colitis
Centre Hospitalier Universitaire de Besançon
2016-2025
Université de franche-comté
2016-2025
Inserm
2013-2025
Université Bourgogne Franche-Comté
2016-2023
Université de Bourgogne
2016-2023
Innovation Plasturgie Composites
2023
Hacettepe University
2023
Turkish Thoracic Society
2023
Université de Reims Champagne-Ardenne
2023
Hôpital Maison Blanche
2023
In this editorial we discuss the place of artificial intelligence (AI) in writing scientific articles and especially editorials. We asked chatGPT « to write an for Annals Rheumatic Diseases about how AI may replace rheumatologist ». chatGPT's response is diplomatic describes as a tool help but not him. already used medicine, image analysis, domains are infinite it possible that could quickly or rheumatologists articles. ethical aspects future role rheumatologists.
To examine the course of interstitial lung disease associated with rheumatoid arthritis (RA-ILD) in France on treatment Janus kinase inhibitors (JAKis) using MAJIK-SFR registry. Prospective national multicentre observational study identifying patients RA-ILD from Pulmonary assessment data were collected at JAKi initiation and follow-up visits (6 months, 12 months a median 21 postinclusion), including chest high-resolution CT (HRCT), pulmonary function tests (forced vital capacity (FVC)...
To compare (18)F-fluoro-dexoxyglucose PET/CT (FDG-PET/CT) findings in patients with polymyalgia rheumatica (PMR) and controls without rheumatologic disease.We retrospectively included 50 a diagnosis of PMR as well 53 neoplasm control group. All underwent FDG-PET/CT. Seventeen hotspots were analysed. We performed semi-quantitative analysis FDG uptake (4-point score from 0 to 3). The cut-offs for the number sites high activity assessed using receiver operating characteristics curves odds...
The objectives of this study were to describe the incidence major adverse cardiovascular events (MACEs) in French patients newly benefiting from Long-term Illness scheme (LTI) for AS and evaluate effect various treatments on risk MACE occurrence.This national cohort was based medico-administrative database SNDS containing data hospitalization, LTI, outpatient care consumption. All receiving LTI benefits 2010 2013 included. final follow-up date 31 December 2018. occurrences MACEs [stroke...
Objective. To evaluate the efficacy and safety of rituximab (RTX) in several subsets spondyloarthritis (SpA) using data AIR (Autoimmunity Rituximab) registry. Methods. All patients receiving RTX for SpA, prospectively included registry from September 2005 to 2010, were retrospectively analyzed. The response treatment was evaluated by Bath Ankylosing Spondylitis Disease Activity Index axial disease, joint count peripheral C-reactive protein reduction. Results. Among 595 registry, 26 with SpA...
Background: Patients with rheumatoid arthritis (RA) and other chronic inflammatory rheumatic disorders have increased risk of cardiovascular disease (CVD) venous thromboembolism (VTE) compared the general population. Moreover, recent data raised concerns around a possible major CV events (MACE) VTE in patients treated JAK inhibitors (JAKi). In October 2022, PRAC has recommended measures to minimize serious side effects, including conditions VTE, associated all approved diseases. Objective:...
Objectives To determine the cumulative incidence and identify factors associated with difficult-to-treat axial spondyloarthritis (D2T-axSpA) in French patients newly benefiting from ‘long-term illness’ (LTI) social security scheme for (axSpA). Methods This national cohort study was based on National Medico-Administrative Database, SNDS, which contains data hospitalisation, LTI outpatient care consumption. All receiving benefits ankylosing spondylitis (AS) between 2010 2013 were included...